Medifast (MED) Income towards Parent Company (2010 - 2026)

Medifast (MED) has 17 years of Income towards Parent Company data on file, last reported at -$2.1 million in Q1 2026.

• Quarterly Income towards Parent Company fell 176.61% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.0 million (down 187.98% YoY) and the FY2025 annual result came in at -$18.6 million, down 991.39% from the prior year.
• Income towards Parent Company improved to -$2.1 million in Q1 2026, from -$18.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $41.8 million in Q1 2022 to a low of -$18.1 million in Q4 2025.
• A 5-year average of $13.2 million and a median of $6.0 million in 2023 frame the typical range for Income towards Parent Company.
• The widest YoY moves for Income towards Parent Company: up 130.43% in 2025, down 2357.43% in 2025.
• Tracing MED's Income towards Parent Company over 5 years: stood at $26.5 million in 2022, then tumbled by 77.24% to $6.0 million in 2023, then tumbled by 86.73% to $801000.0 in 2024, then sank by 2357.43% to -$18.1 million in 2025, then jumped by 88.16% to -$2.1 million in 2026.
• The last three Income towards Parent Company figures came in at -$2.1 million (Q1 2026), -$18.1 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.